欢迎来到天天文库
浏览记录
ID:39343899
大小:417.35 KB
页数:6页
时间:2019-07-01
《那格列奈临床应用中国专家共识》由会员上传分享,免费在线阅读,更多相关内容在行业资料-天天文库。
1、万方数据生堡凼筮塑盐遂盘查垫!!生§旦筮!!鲞星i翅垡!也』垦!i堡互!!!丛!堂:丛型垫!!:!尘:!!:塾:!那格列奈临床应用中国专家共识宁光(以下以姓氏拼音为序)陈璐璐陈名道冯凭高妍郭晓蕙李延兵陆菊明潘长玉田浩明王卫庆薛耀明严励曾龙驿朱大龙邹大进【提要】胰岛素早时相分泌缺陷是导致餐后血糖升高的重要原因。那格列奈是一种速效胰岛素促泌剂,可通过恢复2型糖尿病患者胰岛素早时相分泌以降低餐后血糖。其有效性和安全性得到了充分验证,对2型糖尿病的临床应用也日益广泛。2010年中国2型糖尿病治疗指南将磺脲类与格列奈类统称为胰岛
2、素促泌剂,均作为备选的一线药物。AACE/ACE的共识声明中指出,格列奈类已成为二甲双胍之后的重要选择之一。为了进一步指导那格列奈临床应用,国内16位知名内分泌代谢专家经过认真讨论,拟写了此共识。本共识结合国内外证据,对那格列奈的研究结果进行了系统回顾与总结,对如何l临床合理有效应用那格列奈提出指导性建议,供临床医师参考。【关键词】那格列奈;中国专家共识;糖尿病,2型Clinicalapplicationofnateglinide:aChineseexpertconsensusNINGGuang+,CHENLu—lu,
3、CHEN删增-dao,FENPtng,GAOYan,GUOXiao—hui,LIYan—bing,LUJu—ming,PANChang-yu,TIANHao—ming,WANGWei—qing,XUEYao一赢昭,yAⅣ丘,ZEⅣG幻昭一一,ZHUDa—long,ZOUDajin.’DepartmentofEndocrinologyandMetabolicDisease.ShanghaiClinicalCenterforEndocrineandMetabolicDisease,ShanghaiInstituteofEn
4、docrineandMetabolicDiseases,ShanghaiJiaotongUniversitySchoolofMedicine,Shanghai200025,China【Summary】Impairedeadyphaseinsulinsecretionisanimportantreasonforleadingtopostprandialhyperglycemia.Nateglinideisarapid-actinginsulinsecretagogue,whichreducespostprandialbl
5、oodglucoseoftype2diabeticpatientbyrestoringearlyphaseinsulinsecretion.Theefficacyandsafetyhavebeenfullyverifiedbyclinicaladministrationanditismorewidelyusedtotreattype2diabeticpatients.Bothsulfonylureasandglinideswerenamedinsulinsecretagogueagentsandregardedasal
6、ternativefirst.1inedrugsinthe2010ChineseGuidelinefortreatmentoftype2diabetes.AACE/ACEConsensusstatementclaimedthatglinideswouldbeoneoftheimportantchoicesaftermetformin.Inordertofurtherguidetheclinicalapplicationofnateglinide,16nationalspecialistsinthefieldofendo
7、crinologyandmetabolismofChinadiscussed,drafted.andeditedthisconsensus.necurrentconsensuscombinedclinicalevidencesathomeandabroad,systematicallyreviewedandsummarizedtheresultsofthesestudiesaboutnateglinide.Itwillprovideguidingrecommendationsandreferenceconcerning
8、howtoreasonablyandeffectivelyusenateglinideintheclinicalpractice.【Keywords】Nateglinide;Chineseexpertconcensus;DiabetesmeUitus,type2一、那格列奈的药代动力学以及作用特点那格列奈是口服降糖药中唯一的苯丙氨
此文档下载收益归作者所有